Bowen Acquisition Corp (BOWN) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
BOWN currently has 2.99M outstanding shares. with significant dilution risk as 6M authorized shares could dilute existing holders by 200.4%. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Aug 15, 2025 |
10-Q filing | 3.0M shares outstanding |
3M | 6M |
| Jul 08, 2025 |
10-Q filing | 3.0M shares outstanding |
3M | 6M |
| Apr 15, 2025 |
10-K filing | 3.0M shares outstanding |
3M | 6M |
| Jan 13, 2025 |
8-K filing: Bowen Acquisition Corp entered into a Prepaid Forward Purchase Agreement with Qianzhi Group Holding and Harraden Circle Investments for the potential purchase of up to 550,000 Company Ordinary Shares from redeeming public shareholders in connection with a business combination. |
9.2M | 6M |
| Dec 05, 2024 |
8-K filing: Bowen Acquisition Corp entered into a subscription agreement with an accredited investor to issue 500,000 ordinary shares at $10.00 per share for gross proceeds of $5,000,000, contingent upon the consummation of the Business Combination. ($5.0M proceeds) |
9.2M | 6M |
| Nov 14, 2024 |
10-Q filing | 9.2M shares outstanding |
9.2M | 6M |
| Aug 13, 2024 |
10-Q filing | 9.2M shares outstanding |
9.2M | 6M |
| May 17, 2024 |
10-Q filing | 9.2M shares outstanding |
9.2M | 6M |
| Mar 29, 2024 |
10-K filing | 9.2M shares outstanding |
9.2M | 6M |
| Jan 24, 2024 |
8-K filing: Bowen Acquisition Corp entered into an agreement for a business combination with Shenzhen Qianzhi BioTechnology Co. Ltd., where Bowen Merger Sub will merge with NewCo, and NewCo shareholders will receive Parent Ordinary Shares. |
9.2M | 6M |
| Nov 09, 2023 |
10-Q filing | 9.2M shares outstanding |
9.2M | 6M |
| Aug 25, 2023 |
10-Q filing | 9.2M shares outstanding |
9.2M | 6M |
| Aug 15, 2023 |
8-K filing: Bowen Acquisition Corp consummated its IPO of 6,000,000 units at $10.00 per unit, generating gross proceeds of $60,000,000, and a private placement of 330,000 units at $10.00 per unit, generating total proceeds of $3,300,000. The underwriters also exercised their over-allotment option in full to purchase an additional 900,000 Units at $10.00 per Unit, generating gross proceeds of $9,000,000. In connection with this sale, Createcharm Holdings Ltd and EarlyBirdCapital, Inc. also purchased an additional 31,500 Private Placement Units from the Company. ($72.3M proceeds) |
N/A | 6M |
| Jul 20, 2023 |
8-K filing: Bowen Acquisition Corp consummated an IPO of 6,000,000 units at $10.00 per unit, a private placement of 330,000 units at $10.00 per unit, and the underwriters exercised their over-allotment option to purchase an additional 900,000 Units at $10.00 per unit. ($72.62M proceeds) |
N/A | 6M |
| Jun 13, 2023 |
S-1/A filing: Bowen Acquisition Corp is offering 6,000,000 units at $10.00 per unit for a total of $60,000,000 in an initial public offering. |
N/A | 6M |
| May 19, 2023 |
S-1 filing: Initial public offering of units, each consisting of one ordinary share and one right to receive one-tenth of one ordinary share, with an offering price of $10.00 per unit, for a total proposed amount of $60,000,000. |
N/A | 6M |